Refine by
Biomarker Detection Suppliers & Manufacturers
17 companies found
based inRichmond, BRITISH COLUMBIA (CANADA)
GenomeMe Lab Inc. is a Vancouver-based biotech company specializing in mouse and rabbit IHC (immunohistochemistry) monoclonal antibodies for clinical diagnostic use. Since our inception in 2017, our goal has been to develop each of the 260+ clinical ...
Immunotherapy is emerging as the treatment of choice for cancer and has been used to successfully cure many cancers already. However, immunotherapy requires precision diagnostics using IHC-based biomarker detection, ...
based inDenver, COLORADO (USA)
Eleven P15 creates Next Generation Diagnostics and Treatment for Pulmonary Fibrosis. The company focuses on the development of biomarkers that enable early detection of idiopathic pulmonary fibrosis and the discovery of genetically-targeted ...
Eleven P15 focuses on the development of biomarkers that enable early detection of idiopathic pulmonary fibrosis, and the discovery of genetically-targeted therapeutic approaches to treat and prevent this incurable ...
based inReno, NEVADA (USA)
DxDiscovery is a biotechnology Research & Development firm. The corporate goal is to develop quality, high-affinity antibodies to microbial antigens. These antibodies are incorporated into rapid POC diagnostics, or they may be developed as ...
based inNotting Hill, AUSTRALIA
INOVIQ Ltd (ASX:IIQ) (INOVIQ) is developing and commercialising an innovative portfolio of diagnostic and exosome-based solutions for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases to improve patient outcomes ...
based inCambridge, UNITED KINGDOM
Owlstone Medical is developing a breathalyzer for disease. With a goal to find ways to improve non-invasive diagnostics for respiratory diseases, liver diseases, cancer, digestive health and other conditions. Our mission is to save 100,000 lives and ...
based inEdmonton, ALBERTA (CANADA)
Nanostics is a medical device and biotechnology company with a mission to provide clarity to people about their health by enabling better diagnosis and improving health care decisions through machine learning and extracellular vesicle detection. ...
based inBoston, MASSACHUSETTS (USA)
SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 790 institutions in over 70 countries. Our network advances data-driven medicine to improve health outcomes and economics worldwide. We offer a ...
based in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
based inHuningue, FRANCE
FIRALIS is a biotechnology company located in the very heart of BioValley, on the true triple border of FR-DE-CH, only a few minutes walking distance to Basel, the pharmaceutical capital of Europe. Firalis creates novel values via biomarker ...
based inValencia, SPAIN
Quibim, with headquarters in Valencia, Spain, is a global leader in whole-body medical imaging analysis. Quibim products are used worldwide by leading research teams. Partners use Quibim Precision®, a whole-body imaging ecosystem, for a wide range ...
based inMissoula, MONTANA (USA)
FYR Diagnostics is developing a powerful portfolio of biomarker detection technologies with a focus on nucleic acid amplification. Our mission is to commercialize and implement these novel technologies to enable the accelerated prediction, ...
based inRichmond, BRITISH COLUMBIA (CANADA)
BioMark is an oncology-focused company with advanced near-to- market liquid biopsy diagnostic technologies. Our technology improves patient comfort, outcomes and early cancer detection. Biomark owns various intellectual properties, developed for the ...
based inTaipei City, TAIWAN
Instant NanoBiosensors (INB) is an innovative life sciences company that has developed next generation, ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Our platform , Light ...
based inSeoul, SOUTH KOREA
We detect and analyze genomic profile of tumor DNA with a single draw of blood. With this comprehensive profile, we provide personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Ultimately, we ...
AlphaLiquid®100 is a test that enables the detection of biomarkers which can predict the efficacy/resistance of targeted therapy for one blood test across 118 cancer-related genes. During cancer ...
based inPalo Alto, CALIFORNIA (USA)
Lucence is a precision oncology company committed to bringing clarity to cancer care. Lucence makes ultrasensitive non-invasive liquid biopsy tests to provide doctors and their patients life-changing information to enable earlier detection and ...
based inBillerica, MASSACHUSETTS (USA)
We are on a mission to change the way in which healthcare is provided by giving researchers the ability to closely examine the continuum from health to disease. In order to make this vision a reality, we brought together the most experienced ...
Unleashing the power of next-generation Simoa® Planar Array technology for robust multiplex circulating biomarker detection at the earliest stages of disease progression - even at healthy baseline levels. The ...
based inActon, MASSACHUSETTS (USA)
Bluejay Diagnostics, Inc. is developing easy-to-use, near patient medical diagnostics tests. Bluejay Diagnostics is focused on improving patient outcomes through a more cost efficient, rapid, near patient product for triage, diagnosis, and ...
Bluejay Diagnostics is pleased to present Symphony, a near-patient biomarker detection platform. Symphony aims to improve healthcare outcomes by providing quantitative clinical chemistry results, vital for triage ...